Share:

FDA Fast Track AIC-316 HSV2 Therapeutic Drug

Provide relief to the 500million suffers of HSV2 worldwide, while significantly reducing the spread of HSV2 and HIV.

AIC-316, produced by AICURIS hasproven both safe and effective in Phase I and Phase II trials. This drug is revolutionary and has the real potential to bring back normalcy to the half billion people worldwide suffering from HSV2. Additionally, this drug will significantly reduce;if not nearly eliminate transmission of HSV2 from infected persons to theirpartners.



It is estimated there is 500,000new cases of HSV2 each year in the United States alone. That is on average 2,200 people PER DAY that get a disease that is stigmatized, causes both physical and psychological problems and can effectively wreak havoc on their lives as long as they are breathing. Further, according to CDCestimates 50 million people in the US alone are already affected by this virus. Having this virus increases one?s chances of acquiring HIV between two and five fold due to HSV causing the immune cells that HIV attacks to become more enriched with the CCR5 receptor that HIV needs to attack immune cells.



We want our lives back. We are voting, taxpaying citizens of this country asking for a normal life ? a life without fear of perpetually having outbreaks ?a life without fear of having to be alone ? a life without fear of ever being desirable due to fear of transmitting a lifelong virus to someone else ? a lifewithout fear of giving birth due to passing it to newborns eyes ? a lifewithout fear of acquiring HIV.



In closing, we STRONGLY ASK the FDA to fast-track the AIC-316 drug such that people across the world, including US citizenry, can begin to live normal healthy lives again while also stopping the spread of HSV2 and HIV.



May God Bless this Petition, all Supporters, and our Government Officials.